Previous studies have revealed the regulatory role of RBMS3 in deactivating the Wnt/β‐catenin signaling pathway and repressing the expressions of diverse genes, including β‐catenin, cyclin D1, and C‐myc, within breast cancer cells.7, 18, 19. This evidence concerns the gene RBMS3 and breast cancer.